Skip to main content
VVOS logo

VVOS · Vivos Therapeutics, Inc.

$0.40 -0.01 (-2.65%) At close · Jul 22
Market Cap
$5.61M
Shares
13.89M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
52/100
Short interest 8.5% of shares — P86 Days to cover 1.0 — P15 Price vs VWAP -47.8% — P4 Short-volume trend -4.9% — P33 Short interest change +23.9% — P80 Worst FTD 3.94% of shares — P97

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 1,174,295 947,441 +226,854 1.00
2026-06-15 947,441 786,598 +160,843 1.00
2026-05-29 786,598 978,065 -191,467 4.91
2026-05-15 978,065 716,108 +261,957 6.44
2026-04-30 716,108 554,017 +162,091 2.08
2026-04-15 554,017 316,118 +237,899 1.27
2026-03-31 316,118 484,373 -168,255 2.66
2026-03-13 484,373 478,895 +5,478 4.27
2026-02-27 478,895 465,161 +13,734 6.70
2026-02-13 465,161 462,619 +2,542 3.59
2026-01-30 462,619 415,924 +46,695 3.17
2026-01-15 415,924 282,105 +133,819 2.57
2025-12-31 282,105 290,087 -7,982 2.91
2025-12-15 290,087 303,793 -13,706 2.17
2025-11-28 303,793 315,028 -11,235 2.40
2025-11-14 315,028 302,560 +12,468 2.73
2025-10-31 302,560 292,381 +10,179 1.16
2025-10-15 292,381 579,802 -287,421 1.20
2025-09-30 579,802 260,244 +319,558 1.00
2025-09-15 260,244 194,286 +65,958 2.57
2025-08-29 194,286 264,649 -70,363 1.23
2025-08-15 264,649 251,822 +12,827 1.29
2025-07-31 251,822 310,373 -58,551 1.31
Showing 1–23 of 23 settlements
Key facts CIK 1716166 CUSIP 92859E207 13F (30d) 6 filings 6 filers Visit website Investor relations